In September in San Sebastián, Spain, a seminar dedicated to the project "Understanding Lung Cancer related risk factors and their impact" (LUCIA) was held, in which a representative from Latvia - professor, Clinical and Preventive Medicine of the University of Latvia ( LU KPMI) institute's leading researcher, pulmonologist Alvils Krams.

The seminar consisted of two sessions - in the first, lung cancer was examined from a clinical perspective, while in the second session, seminar participants presented the new technological approaches and solutions that the LUCIA project intends to implement for the prevention, detection and diagnosis of lung cancer. The event was attended by 22 international partners of the LUCIA project, clinical specialists, representatives of industry administrations and local companies.

Lung cancer is considered the deadliest of cancers. Although smoking is considered one of the most important factors in the development of lung cancer, non-smokers also get lung cancer.

The goal of the LUCIA project is to improve the early diagnosis, prevention and treatment of lung cancer, with a special focus on rarer types of lung cancer. As a result of the project's research, recommendations for an early diagnosis program and methods for effective prevention of lung cancer will be developed.
LUCIA is managed by the Technion Institute of Technology in Israel. In Latvia the project is implemented by the scientists of the Institute of Clinical and Preventive Medicine of the Latvian University under the scientific guidance of prof. Alvils Krams.

This project has received funding from the European Union’s research and innovation programme Horizon Europe under grant agreement No 101096473.

Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union. Neither the European Union nor the granting authority can be held responsible for them.